DIAGNOS et l'ÉTS présenteront une recherche novatrice sur le dépistage de masse de l'œdème maculaire à ARVO 2023
14 févr. 2023 10h37 HE
|
DIAGNOS inc.
BROSSARD, Québec, 14 févr. 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (« DIAGNOS », la « Société » ou « nous ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF) est un leader dans le dépistage...
DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023
14 févr. 2023 10h37 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is a leader in early detection of critical health issues...
DIAGNOS Announces Grant of Stock Options
10 févr. 2023 15h56 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) -- February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical...
DIAGNOS obtient le feu vert pour l'utilisation de ses outils de dépistage de la Rétinopathie Diabétique dans les hôpitaux du Québec
31 janv. 2023 10h04 HE
|
DIAGNOS inc.
BROSSARD, Québec, 31 janv. 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (« DIAGNOS », la « Société » ou « nous ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un leader dans le dépistage précoce...
DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals
31 janv. 2023 10h04 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues...
Access Recognized in Two Categories by Inc.’s Prestigious Inaugural Power Partner Awards
24 janv. 2023 11h30 HE
|
Access Information Management Shared Services, LLC
WOBURN, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, today announced that it has been recognized by Inc....
DIAGNOS Announces Closing of Private Placement
13 janv. 2023 14h12 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the...
MamaMancini’s Appoints Meghan Henson to Board of Directors
19 déc. 2022 08h31 HE
|
MamaMancini's Holdings, Inc.
Seasoned Human Resources Executive Brings 20+ Years of Experience to the Board of Directors EAST RUTHERFORD, NJ, Dec. 19, 2022 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a...
DIAGNOS Provides Additional Information to the Closing of Private Placement
15 déc. 2022 15h00 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Dec. 15, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the...
DIAGNOS Announces Closing of Private Placement
12 déc. 2022 14h30 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Dec. 12, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the...